Literature DB >> 9895094

The growth of microorganisms in propofol and mixtures of propofol and lidocaine.

I Wachowski1, D T Jolly, J Hrazdil, J C Galbraith, M Greacen, A S Clanachan.   

Abstract

UNLABELLED: Propofol emulsion supports bacterial growth. Extrinsic contamination of propofol has been implicated as an etiological event in postsurgical infections. When added to propofol, local anesthetics (e.g., lidocaine) alleviate the pain associated with injecting it. Because local anesthetics have antimicrobial activity, we determined whether lidocaine would inhibit microbial growth by comparing the growth of four microorganisms in propofol and in mixtures of propofol and lidocaine. Known quanta of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans were inoculated into solutions of 1% propofol, 0.2% lidocaine in propofol, 0.5% lidocaine in propofol, 0.5% lidocaine in isotonic sodium chloride solution, and 0.9% isotonic sodium chloride solution. All microorganisms were taken from stock cultures and incubated for 24 h. Growth of microorganisms in each solution was compared by counting the number of colony-forming units grown from a subculture of the solution at 0, 3, 6, 12 and 24 h. Propofol supported the growth of E. coli and C. albicans. Propofol maintained static levels of S. aureus and was bactericidal toward P. aeruginosa. The addition of 0.2% and 0.5% lidocaine to propofol failed to prevent the growth of the studied microorganisms. The effect of 0.5% lidocaine in isotonic sodium chloride solution did not differ from the effects of isotonic sodium chloride solution alone. We conclude that lidocaine, when added to propofol in clinically acceptable concentrations, does not exhibit antimicrobial properties. IMPLICATIONS: Local anesthetics such as lidocaine have antimicrobial activity. Propofol supports the growth of bacteria responsible for infection. Bacteria were added to propofol and propofol mixed with lidocaine. The addition of lidocaine to propofol in clinically relevant concentrations did not prevent the growth of bacteria. The addition of lidocaine to propofol cannot prevent infection from contaminated propofol.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9895094     DOI: 10.1097/00000539-199901000-00039

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

1.  Synthesis and evaluation of hydroponically alginate nanoparticles as novel carrier for intravenous delivery of propofol.

Authors:  Alireza Hassani Najafabadi; Saman Azodi-Deilami; Majid Abdouss; Hamid Payravand; Sina Farzaneh
Journal:  J Mater Sci Mater Med       Date:  2015-03-06       Impact factor: 3.896

Review 2.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

3.  A novel, lipid-free nanodispersion formulation of propofol and its characterization.

Authors:  Hongming Chen; Zhong Zhang; Orn Almarsson; Jean-Francois Marier; Dina Berkovitz; Colin R Gardner
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

4.  Design and evaluation of microemulsions for improved parenteral delivery of propofol.

Authors:  Abhijit A Date; Mangal S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2008-01-19       Impact factor: 3.246

5.  Fospropofol: Is there an infusion regimen for propofol equivalence?

Authors:  Glen Atlas
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

6.  Selected Antimicrobial Activity of Topical Ophthalmic Anesthetics.

Authors:  Margaret M Reynolds; Kerryl E Greenwood-Quaintance; Robin Patel; Jose S Pulido
Journal:  Transl Vis Sci Technol       Date:  2016-07-05       Impact factor: 3.283

Review 7.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

8.  The preclinical pharmacological study on HX0969W, a novel water-soluble pro-drug of propofol, in rats.

Authors:  YuJun Zhang; YingYing Jiang; HaiYan Wang; Bin Wang; Jun Yang; Yi Kang; Jun Chen; Jin Liu; Wen-Sheng Zhang
Journal:  PeerJ       Date:  2020-04-16       Impact factor: 2.984

9.  [The antimicrobial activity of ephedrine and admixture of ephedrine and propofol: an in vitro study].

Authors:  Serkan Tulgar; Elcin Akduman Alasehir; Onur Selvi
Journal:  Braz J Anesthesiol       Date:  2017-09-02

10.  A Phase 1c Trial Comparing the Efficacy and Safety of a New Aqueous Formulation of Alphaxalone with Propofol.

Authors:  John Monagle; Lyndon Siu; Jodie Worrell; Colin S Goodchild; Juliet M Serrao
Journal:  Anesth Analg       Date:  2015-10       Impact factor: 6.627

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.